TestDynamics
Maker of Satori, a vendor-neutral platform that runs a hospital's imaging AI tools as one program.
The record
- Vertical
- Imaging & Diagnostics
- Sub-segment
- Vendor-neutral imaging AI platform
- Product type
- Platform software
- Stage
- Series A
- Headquarters
- Austin, TX, United States
- Region
- North America
What they do
TestDynamics (legal name TestDynamics Holdings Inc.) makes Satori, a vendor-neutral imaging AI platform that runs a hospital's imaging AI tools as one program, with one agreement, one connection to the hospital's systems and one view for clinicians. The company says it does not build or sell algorithms. It matches AI from across the market, tests each tool on the hospital's own patient data before anyone commits, presents findings where radiologists already read, requires radiologist approval before findings reach the report, and replaces a tool that falls short of pre-agreed goals under the same agreement. On November 16, 2026, TestDynamics announced $9 million in funding, with a Series A led by Healthier Capital and participation from Cedars-Sinai Technology Ventures.
Leadership & founders
- Lior Eshel
Founder and CEO
Investors
- Healthier Capital
- Cedars-Sinai Technology Ventures
History and progression
How TestDynamics got here, step by step.
16 November 2026
$9 million Series A
TestDynamics announced $9 million in funding, with a Series A led by Healthier Capital and participation from Cedars-Sinai Technology Ventures, to grow its clinical validation team, bring Satori to more health systems and extend it into new imaging subspecialties.
Key products
- Satori
- Vendor-neutral imaging AI platform. Tests each algorithm on the hospital's own patient data before commitment, surfaces findings in the radiologist's existing reading workflow, requires radiologist approval before findings reach the report, and swaps tools that miss pre-agreed goals under the same agreement.
Recent news
16 November 2026
TestDynamics Secures Series A Funding Led by Healthier Capital16 November 2026
$9 million Series A round18 November 2026
Lior Eshel, Founder and CEO
Your daily HealthTech Signal
No hype. Just signal.
Get the latest HealthTech news, understand why it matters, and see where the industry is headed.



Read by teams at companies like: